Dr. Clyde Jones, MD – Memphis, TN

Overview of Dr. Jones

Dr. Clyde Jones is an oncologist in Memphis, TN and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital - Memphis, Baptist Memorial Hospital-Golden Triangle, Baptist Memorial Hospital-Union County, Baptist Memorial Hospital for Women, Baptist Memorial Hospital-Tipton, Methodist Le Bonheur Germantown Hospital, and Methodist Healthcare Memphis Hospitals. He received his medical degree from University of Alabama School of Medicine and has been in practice 47 years. Dr. Jones accepts several types of health insurance, listed below. He is one of 55 doctors at Baptist Memorial Hospital - Memphis and one of 32 doctors at Methodist Le Bonheur Germantown Hospital who specialize in Oncology. He has 7 publications and over 100 citings.

Education & Training

• London School of Economics and Political ScienceMS, Health Economics, Ms, 2012 - 2014

• Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1978 - 1978

• Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1977 - 1978

• Johns Hopkins UniversityResidency, Internal Medicine, 1976 - 1977

• University of Alabama Medical CenterResidency, Internal Medicine, 1974 - 1976

• University of Alabama School of MedicineClass of 1974

Certifications & Licensure

• TN State Medical License 1995 - 2025

• TX State Medical License 1983 - 2025

• MS State Medical License 1998 - 2024

• MD State Medical License 1976 - 2024

• AL State Medical License 1975 - 2024

• American Board of Internal Medicine Hematology
• American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

• Fellow (FACP) American College of Physicians, 1998
• Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

• 12 citations

  Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.

  Blackwell, K., Blackwell, K., Gascon, P., Gascon, P., Jones, C. M., Jones, C. M., Nixon, A., Nixon, A., Krendyukov, A., Krendyukov, A., Nakov, R., Nakov, R., Li, Y., L...> ;Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Jun 24
• 5 citations

  Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III ...

  Nadia Harbeck, Pere Gascón, Clyde M Jones, Allen Nixon, Andriy Krendyukov, Roumen Nakov, Y. Li, Kimberly L. Blackwell> ;Future Oncology. 2017 Apr 28
• 14 citations

  A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.

  Dana Backlund Cardin, Ramya Thota, Laura W. Goff, Jordan Berlin, Clyde M. Jones, Gregory D. Ayers, Jennifer G. Whisenant, Emily Chan> ;American Journal of Clinical Oncology. 2017 Mar 1
• Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

• Aetna Choice POS II
  Aetna HMO
  BCBS Blue Card PPO
  BCBS Tennessee Network 5
  CIGNA HMO
  CIGNA Open Access
  CIGNA PPO
  Coventry Carelink Health Plans PPO
  

  First Health PPO
  Great West PPO
  Humana ChoiceCare Network PPO
  Humana/ChoiceCare+ Network PPO
  Multiplan PHCS PPO
  Multiplan PPO
  United Healthcare - Direct Choice Plus POS
  United Healthcare - Direct Options PPO
  

• Please verify your coverage with the provider's office directly when scheduling an appointment